ZimVie Inc. (NASDAQ:ZIMV) Shares Purchased by American Century Companies Inc.

American Century Companies Inc. grew its position in shares of ZimVie Inc. (NASDAQ:ZIMV) by 23.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 628,050 shares of the company’s stock after acquiring an additional 121,053 shares during the quarter. American Century Companies Inc.’s holdings in ZimVie were worth $8,761,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of ZIMV. SG Americas Securities LLC boosted its stake in ZimVie by 15.7% during the 4th quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock valued at $155,000 after purchasing an additional 1,508 shares during the period. EMC Capital Management raised its holdings in shares of ZimVie by 47.0% during the fourth quarter. EMC Capital Management now owns 13,802 shares of the company’s stock valued at $193,000 after buying an additional 4,414 shares during the last quarter. Principal Financial Group Inc. bought a new stake in shares of ZimVie during the third quarter valued at approximately $275,000. Bailard Inc. boosted its position in shares of ZimVie by 35.0% during the fourth quarter. Bailard Inc. now owns 21,194 shares of the company’s stock worth $296,000 after buying an additional 5,494 shares during the period. Finally, Y Intercept Hong Kong Ltd bought a new position in ZimVie in the 3rd quarter worth approximately $528,000. Institutional investors own 95.63% of the company’s stock.

Analysts Set New Price Targets

Separately, Needham & Company LLC reissued a “hold” rating on shares of ZimVie in a research note on Thursday, March 13th.

ZimVie Price Performance

Shares of ZimVie stock opened at $10.56 on Thursday. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. The stock has a market cap of $294.06 million, a PE ratio of -0.81 and a beta of 2.10. ZimVie Inc. has a 52 week low of $10.41 and a 52 week high of $22.40. The company’s 50-day moving average price is $12.85 and its two-hundred day moving average price is $13.92.

ZimVie (NASDAQ:ZIMV) last announced its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. The company had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. As a group, sell-side analysts anticipate that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.